CIK 0000874716 · Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010393723
- Phone
- 2075560300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-13 | Hunt Nimrata Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +6,320 | 6,320 | ||
| 2025-02-13 | Hunt Nimrata Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +217 | 217 | ||
| 2025-02-13 | Hunt Nimrata Executive Vice President | Grant or award · Restricted Stock Unit | +1,468 | 1,468 | ||
| 2025-02-13 | FENNELL GEORGE Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +3,415 | 3,415 | ||
| 2025-02-13 | FENNELL GEORGE Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +217 | 217 | ||
| 2025-02-13 | FENNELL GEORGE Executive Vice President | Grant or award · Restricted Stock Unit | +816 | 816 | ||
| 2025-02-13 | Erickson Michael G Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +6,320 | 6,320 | ||
| 2025-02-13 | Erickson Michael G Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +217 | 217 | ||
| 2025-02-13 | Erickson Michael G Executive Vice President | Grant or award · Restricted Stock Unit | +734 | 734 | ||
| 2025-02-13 | Erickson Michael G Executive Vice President | Grant or award · Restricted Stock Unit | +734 | 734 | ||
| 2025-02-11 | Erickson Michael G Executive Vice President | Option exercise | +1,544 | $67.85 | $105K | 20,836.36 |
| 2025-02-11 | Erickson Michael G Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −1,544 | 0 | ||
| 2025-02-10 | FENNELL GEORGE Executive Vice President | Option exercise | +9,986 | $79.54 | $794K | 18,162 |
| 2025-02-10 | FENNELL GEORGE Executive Vice President | Sale | −9,986 | $462.53 | $4.6M | 8,176 |
| 2025-02-10 | FENNELL GEORGE Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −9,986 | 0 | ||
| 2025-02-07 | FENNELL GEORGE Executive Vice President | Option exercise | +1,256 | $79.54 | $100K | 8,176 |
| 2025-02-07 | FENNELL GEORGE Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −1,256 | 0 | ||
| 2025-02-07 | SZOSTAK M ANNE Director | Sale | −3,000 | $465.95 | $1.4M | 3,061 |
| 2024-11-27 | Vandebroek Sophie V. Director | Gift | −224 | 1,249 | ||
| 2024-11-27 | Vandebroek Sophie V. Director | Sale | −344 | $420.44 | $145K | 905 |
Page 25 of 28 · 552 trades